Perillyl alcohol attenuates hypoxia induced right ventricular dysfunction and remodeling by balancing the renin angiotensin aldosterone system in rats
Abstract
Hypoxia induced-pulmonary hypertension (HPH) is a life-threatening cardiovascular disorder prevalent in high-altitude regions. Right ventricular (RV) function and RV—pulmonary arterial (RV—PA) coupling are key to patient prognosis. Perillyl alcohol (POH), a natural compound, holds promise for managing pulmonary arterial hypertension (PAH). This study established HPH rat models via hypobaric chamber simulation (5000 m altitude) to explore the impact of POH on RV structure and function. Using a multi-modal approach, we employed echocardiography to assess RV function and RV-PA coupling. HE and Masson’s trichrome staining for tissue morphology and fibrosis. Immunohistochemistry, immunofluorescence, and western blotting to quantify collagen I/III and α-SMA. MDA, GSH, SOD, GSH-PX, IL-6 and TNF-α levels were measured using their respective commercial kits. ELISA/western blotting to analyze the ACE-Ang II-AT1R and ACE2-Ang (1–7)-MAS axes. Results showed that POH significantly restored RV function and RV-PA coupling, outperforming sildenafil in reducing RV structural changes (RVID-D, RVID-S, RVFT-D, RVFT-S). It normalized hypoxia-elevated hematological parameters (HCT, HGB, RBC), alleviated cardiomyocyte hypertrophy, fibrosis and inflammatory, and reversed RV remodeling. Mechanistically, POH exerted antioxidant effects and modulated the renin–angiotensin–aldosterone system (RAAS), decreasing ACE, Ang II, and AT1R levels while increasing ACE2, Ang (1–7), and MAS expression. In…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.